The influences of risk scores on immune-oncological targets (PD1, CTLA4, and CD19), immunoscore, and immune cell infiltration were then assessed, thus revealing the effect of the butyrate metabolism on ccRCC TIME. Here, CD19 is linked to nonpapillary renal cell carcinoma.